@article{oai:soar-ir.repo.nii.ac.jp:00003759,
 author = {Koiwai,  Keiichiro and Sasaki,  Shigeru and Yoshizawa,  Eriko and Ina,  Hironobu and Fukazawa,  Ayumu and Sakai,  Katsuya and Ozawa,  Takesumi and Matsushita,  Hirohide and Kadoya,  Masumi},
 issue = {2},
 journal = {JOURNAL OF RADIATION RESEARCH},
 month = {Mar},
 note = {To evaluate the validity of a decrease in the radiation dose for patients who were good responders to chemotherapy for localized diffuse large B-cell lymphoma (DLBCL), 91 patients with localized DLBCL who underwent radiotherapy after multi-agent chemotherapy from 1988-2008 were reviewed. Exclusion criteria were as follows: central nervous system or nasal cavity primary site, or Stage II with bulky tumor (>= 10 cm). Of these patients, 62 were identified as good responders to chemotherapy. They were divided into two groups receiving either a higher or a lower radiation dose (32-50.4 Gy or 15-30.6 Gy, respectively). There were no statistically significant differences between the lower and higher dose groups in progression-free survival, locoregional progression-free survival or overall survival. Adaptation of decreased radiation dose may be valid for localized DLBCL patients who show a good response to chemotherapy., Article, JOURNAL OF RADIATION RESEARCH. 55(2):359-363 (2014)},
 pages = {359--363},
 title = {Validity of reduced radiation dose for localized diffuse large B-cell lymphoma showing a good response to chemotherapy},
 volume = {55},
 year = {2014}
}